Sivia Capital Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 2012032 Mill Valley, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$4,263,974

+$2,589,073 QoQ

Shares Held

3,555

+95.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#1,838

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sivia Capital Partners, LLC holds $16,248,994 across 14 Drug Manufacturers - General names. LLY ranks #1 (26.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,555	$4,263,974
2	BMY	Bristol Myers Squibb Co	47,373	$2,729,632
3	MRK	Merck & Co., Inc.	16,440	$2,112,540
4	PFE	Pfizer Inc	82,650	$1,990,212
5	NVS	Novartis AG	6,151	$963,984
6	JNJ	Johnson & Johnson	3,459	$878,482
7	BIIB	Biogen Inc.	3,879	$838,096
8	GSK	GSK plc	10,340	$542,022

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,263,974	3,555	+95.2%	Shares	Sole	2026-07-23
2026-03-31	$1,674,901	1,821	-25.8%	Shares	Sole	2026-05-13
2025-12-31	$2,638,339	2,455	+7.8%	Shares	Sole	2026-02-10
2025-09-30	$1,738,114	2,278	+15.6%	Shares	Sole	2025-10-20
2025-06-30	$1,536,453	1,971	-5.8%	Shares	Sole	2025-09-24
2025-03-31	$1,727,803	2,092	+13.4%	Shares	Sole	2025-04-14
2024-12-31	$1,423,568	1,844	+1.8%	Shares	Sole	2025-01-13
2024-09-30	$1,605,323	1,812	+0.3%	Shares	Sole	2024-10-11
2024-06-30	$1,636,021	1,807	-3.3%	Shares	Sole	2024-08-05
2024-03-31	$1,453,229	1,868	+5.0%	Shares	Sole	2024-04-19
2023-12-31	$1,037,014	1,779	—	Shares	Sole	2024-03-13
No filing history on record for this holder in this stock.